| Dr Srinivasa R Pamulapati, MD | |
|
13250 Washington Ave, Mount Pleasant, WI 53177-1516 | |
| (262) 884-4000 | |
| Not Available |
| Full Name | Dr Srinivasa R Pamulapati |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 34 Years |
| Location | 13250 Washington Ave, Mount Pleasant, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487632196 | NPI | - | NPPES |
| 33343600 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | C165857 (California) | Secondary |
| 207R00000X | Internal Medicine | 41938-020 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aurora Medical Center Kenosha | Kenosha, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aurora Medical Group, Inc. | 6709794258 | 3207 |
News Archive
A novel positron emission tomography imaging method shows promise for noninvasively pinpointing sites of inflammation in people with inflammatory bowel disease, which includes ulcerative colitis and Crohn's disease.
Stateline reports that information about hospital errors dating back to January 2011 will be available to the public on a new website. Meanwhile, a report by the Robert Wood Johnson draws parallels between the nation's most unhealth counties and those that have the highest rates of preventable hospital stays.
Even though multiple sclerosis is largely caused by genetic factors, the risk of patients' relatives developing the disease is lower than previously assumed. This is the conclusion of a new population registry-based study, published in the scientific journal Brain.
By using data from epidemiological investigations and contact-tracing efforts during the initial phase of the coronavirus disease (COVID-19) epidemic in France, researchers were able to appraise secondary clinical attack rates and factors associated with the risk of a contact becoming a case. Their findings are currently available in a medRxiv preprint paper.
The U.S. Food and Drug Administration today approved a new indication for Tasigna (nilotinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood and bone marrow disease linked to a genetic abnormality.
› Verified 7 days ago
| Entity Name | Ascension Medical Group-southeast Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609881077 PECOS PAC ID: 8628980943 Enrollment ID: O20031104000421 |
News Archive
A novel positron emission tomography imaging method shows promise for noninvasively pinpointing sites of inflammation in people with inflammatory bowel disease, which includes ulcerative colitis and Crohn's disease.
Stateline reports that information about hospital errors dating back to January 2011 will be available to the public on a new website. Meanwhile, a report by the Robert Wood Johnson draws parallels between the nation's most unhealth counties and those that have the highest rates of preventable hospital stays.
Even though multiple sclerosis is largely caused by genetic factors, the risk of patients' relatives developing the disease is lower than previously assumed. This is the conclusion of a new population registry-based study, published in the scientific journal Brain.
By using data from epidemiological investigations and contact-tracing efforts during the initial phase of the coronavirus disease (COVID-19) epidemic in France, researchers were able to appraise secondary clinical attack rates and factors associated with the risk of a contact becoming a case. Their findings are currently available in a medRxiv preprint paper.
The U.S. Food and Drug Administration today approved a new indication for Tasigna (nilotinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood and bone marrow disease linked to a genetic abnormality.
› Verified 7 days ago
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
A novel positron emission tomography imaging method shows promise for noninvasively pinpointing sites of inflammation in people with inflammatory bowel disease, which includes ulcerative colitis and Crohn's disease.
Stateline reports that information about hospital errors dating back to January 2011 will be available to the public on a new website. Meanwhile, a report by the Robert Wood Johnson draws parallels between the nation's most unhealth counties and those that have the highest rates of preventable hospital stays.
Even though multiple sclerosis is largely caused by genetic factors, the risk of patients' relatives developing the disease is lower than previously assumed. This is the conclusion of a new population registry-based study, published in the scientific journal Brain.
By using data from epidemiological investigations and contact-tracing efforts during the initial phase of the coronavirus disease (COVID-19) epidemic in France, researchers were able to appraise secondary clinical attack rates and factors associated with the risk of a contact becoming a case. Their findings are currently available in a medRxiv preprint paper.
The U.S. Food and Drug Administration today approved a new indication for Tasigna (nilotinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood and bone marrow disease linked to a genetic abnormality.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Srinivasa R Pamulapati, MD 3301 W Forest Home Ave, Milwaukee, WI 53215-2843 Ph: (262) 884-4000 | Dr Srinivasa R Pamulapati, MD 13250 Washington Ave, Mount Pleasant, WI 53177-1516 Ph: (262) 884-4000 |
News Archive
A novel positron emission tomography imaging method shows promise for noninvasively pinpointing sites of inflammation in people with inflammatory bowel disease, which includes ulcerative colitis and Crohn's disease.
Stateline reports that information about hospital errors dating back to January 2011 will be available to the public on a new website. Meanwhile, a report by the Robert Wood Johnson draws parallels between the nation's most unhealth counties and those that have the highest rates of preventable hospital stays.
Even though multiple sclerosis is largely caused by genetic factors, the risk of patients' relatives developing the disease is lower than previously assumed. This is the conclusion of a new population registry-based study, published in the scientific journal Brain.
By using data from epidemiological investigations and contact-tracing efforts during the initial phase of the coronavirus disease (COVID-19) epidemic in France, researchers were able to appraise secondary clinical attack rates and factors associated with the risk of a contact becoming a case. Their findings are currently available in a medRxiv preprint paper.
The U.S. Food and Drug Administration today approved a new indication for Tasigna (nilotinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood and bone marrow disease linked to a genetic abnormality.
› Verified 7 days ago
Carlos R Galvao-sobrinho, MD, PHD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3805b Spring St Ste 260, Mount Pleasant, WI 53405 Phone: 262-687-8340 Fax: 262-687-8365 | |
Dr. Ubaid Nawaz, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8400 Washington Ave Ste 203, Mount Pleasant, WI 53406 Phone: 262-884-8340 | |
Diana L Turner, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3801 Spring St, Mount Pleasant, WI 53405 Phone: 262-687-4011 Fax: 262-687-4280 | |
Alexandra Beris, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3801 Spring St, Mount Pleasant, WI 53405 Phone: 262-687-4011 | |
Dr. Dajun Wang, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13250 Washington Ave, Mount Pleasant, WI 53177 Phone: 888-720-2012 | |
Jonathan Rathod, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 3803 Spring St, Mount Pleasant, WI 53405 Phone: 262-687-5236 | |
Dr. Boby G Theckedath, M.D Internal Medicine Medicare: Medicare Enrolled Practice Location: 8400 Washington Ave, Mount Pleasant, WI 53406 Phone: 262-884-4000 Fax: 262-884-4177 |